Kylie Jenner Dragged for 'Korean Ozempic' Cutting Jelly Promo

Kylie Jenner promoted pomegranate-flavored Cutting Jelly as a digestion and debloating aid in a January 10 TikTok video. Dubbed 'Korean Ozempic,' the product drew sharp criticism for irresponsible endorsement. Fans question its safety compared to proven GLP-1 medications.

Kylie Jenner's Controversial Cutting Jelly Promotion

In a January 10 TikTok video, Kylie Jenner described the Cutting Jelly as "amazing." She squeezed the red, pomegranate-flavored jelly from its tube during a "get ready with me" routine for her last fitting before an event.

What She Said About the Product

"I've added a new favorite to my routine: pomegranate-flavored Cutting Jelly."
"This is not a typical jelly. This is a Cutting Jelly for digestion, debloating."

Dubbed 'Korean Ozempic,' the viral product sparked backlash, with fans labeling her promotion "so irresponsible."

Source Information

Originally published by RadarOnline.Read the original article →

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Health & Wellness

Ozempic and Male Fertility: Can Semaglutide Boost Sperm Quality?

Emerging research indicates that GLP-1 medications, including Ozempic and Mounjaro, may offer unexpected benefits for male reproductive health by addressing underlying metabolic issues.

7 min read

Health & Wellness

Semaglutide and Male Fertility: New Study Reveals Testosterone Boost

Can GLP-1 medications like Ozempic or Wegovy improve male fertility? A new study indicates potential benefits for testosterone and sperm health, but what does this mean for patients?

7 min read

Health & Wellness

Semaglutide and Blood Pressure Meds: Why Dizziness Risk Is Rising

A new study reveals a potential safety concern when combining GLP-1 medications with blood pressure drugs, highlighting the importance of monitoring hypotensive episodes in select patients.

8 min read

Same topic: Ozempic

All Ozempic articles →

GLP-1 Medications

How to Keep Weight Off After Ozempic: Proven Strategies

Stopping Ozempic often leads to weight regain—up to 7% in trials or two-thirds within a year. While continuing semaglutide helps sustain losses, lifestyle changes and maintenance dosing offer alternatives. Work with your healthcare team for a personalized plan to keep the weight off long-term.

6 min read

GLP-1 Medications

Ozempic Fuels Tapatío Hot Sauce Boom: L.A. Icon's Story

Ozempic isn't just transforming waistlines—it's igniting a surge in hot sauce sales like Tapatío's. As millions embrace GLP-1 drugs, cravings for bold flavors skyrocket, propelling L.A.'s iconic brand into national expansion under new owners Highlander Partners. This is the untold story of family legacy meeting metabolic health trends.

5 min read

GLP-1 Medications

Taking GLP-1s? Doctors Stress Movement and Mental Health Too

Jelon Smart from Savannah dropped 110 pounds on Ozempic—but credits her intensive workout regimen too. Facing severe ankle swelling from Achilles tendinitis at 285 pounds, she transformed her life. Doctors remind GLP-1 users: movement and mental health are essential alongside medication.

5 min read

More in Weight Management

Health & Wellness

Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39

The journey to weight loss can be challenging, and for many, advanced medications like GLP-1 injectables offer a crucial pathway. However, their high cost often presents a significant barrier. Hers is changing this landscape by making popular GLP-1 and other weight loss treatments more accessible and affordable than ever before.

7 min read

Medical News

Retatrutide Phase 3 Results: 28% Weight Loss and the Triple Agonist Promise

Eli Lilly has released pivotal Phase 3 trial data for retatrutide, a triple agonist showing up to 28% body weight reduction and significant improvements in diabetes and sleep apnea.

7 min read

Medical Insights

Beyond GLP-1s: Unlocking Better Diabetes Control with Korlym

For individuals struggling with difficult-to-control type 2 diabetes and weight management, even powerful GLP-1 medications might not be enough. New research highlights the significant role of hypercortisolism and the promising potential of Korlym in optimizing treatment outcomes.

6 min read